1. Repository of OAI
Ελληνικά   English  

Browsing by Author Mikhailidis, D. P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 27 to 46 of 130 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Early statin therapy in patients with acute coronary syndromeLiberopoulos, E. N.; Daskalopoulou, S. S.; Mikhailidis, D. P.24-Nov-2015-
Early vascular benefits of statin therapyTsiara, S.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?Kostapanos, M. S.; Katsiki, N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrateChristidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Cariolou, M.; Ganotakis, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Symeonidis, A. N.; Mercouris, B. R.; Pehlivanidis, A.; Bouloukos, V. I.; Elisaf, M. S.24-Nov-2015-
The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial samplingGoudevenos, J. A.; Bairaktari, E. T.; Chatzidimou, K. G.; Milionis, H. J.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
The effect of cholesterol-lowering treatment on renal functionLiberopoulos, E. N.; Mikhailidis, D. P.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
Effect of ciprofibrate on C-reactive protein and fibrinogen levelsRizos, E.; Kostoula, A.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymesRizos, E.; Bairaktari, E.; Ganotakis, E.; Tsimihodimos, V.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Filippatos, T.; Saougos, V.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride valuesTsimihodimos, V.; Kostoula, A.; Kakafika, A.; Bairaktari, E.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised studyAthyros, V. G.; Mikhailidis, D. P.; Didangelos, T. P.; Giouleme, O. I.; Liberopoulos, E. N.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Burroughs, A. K.; Elisaf, M. S.24-Nov-2015-
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed DyslipidaemiaFlorentin, M.; Tselepis, A. D.; Elisaf, M. S.; Rizos, C. V.; Mikhailidis, D. P.; Liberopoulos, E. N.24-Nov-2015-
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemiaNakou, E. S.; Filippatos, T. D.; Georgoula, M.; Kiortsis, D. N.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli studyFilippatos, T. D.; Kiortsis, D. N.; Liberopoulos, E. N.; Georgoula, M.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot studyFlorentin, M.; Liberopoulos, E. N.; Filippatos, T. D.; Kostara, C.; Tselepis, A.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S.24-Nov-2015-
Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart diseaseAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Bouloukos, V. I.; Pehlivanidis, A. N.; Symeonidis, A. N.; Elisaf, M. S.24-Nov-2015-
Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE studyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Bouloukos, V. I.; Pehlivanidis, A. N.; Symeonidis, A. N.; Kakafika, A. I.; Daskalopoulou, S. S.; Elisaf, M. S.24-Nov-2015-
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) studyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Symeonidis, A. N.; Pehlivanidis, A. N.; Bouloukos, V. I.; Elisaf, M. S.24-Nov-2015-
Showing results 27 to 46 of 130 < previous   next >